Found: 16
Select item for more details and to access through your institution.
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 215, doi. 10.1111/dom.15307
- By:
- Publication type:
- Article
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1964, doi. 10.1111/dom.15063
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1152, doi. 10.1002/cpt.3185
- By:
- Publication type:
- Article
Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1185, doi. 10.1002/cpt.2814
- By:
- Publication type:
- Article
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1589, doi. 10.1007/s40262-020-00903-0
- By:
- Publication type:
- Article
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1601, doi. 10.1007/s40262-020-00901-2
- By:
- Publication type:
- Article
Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 8, p. 1709, doi. 10.1007/s13300-020-00848-4
- By:
- Publication type:
- Article
Drug Interaction Involving Direct or Indirect Cytokine Modulation Should Be Investigated in Select Circumstances.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 10, p. 1373, doi. 10.1002/jcph.1303
- By:
- Publication type:
- Article
Disease–Drug Interactions in Inflammatory States via Effects on CYP‐Mediated Drug Clearance.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 849, doi. 10.1002/jcph.1093
- By:
- Publication type:
- Article
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles.
- Published in:
- CTS: Clinical & Translational Science, 2018, v. 11, n. 1, p. 46, doi. 10.1111/cts.12497
- By:
- Publication type:
- Article
108-LB: Ultrarapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Healthy Chinese Subjects.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-108-LB
- By:
- Publication type:
- Article
1036-P: Bioequivalence of Ultra-Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1036-P
- By:
- Publication type:
- Article
1018-P: Ultra-Rapid Lispro (URLi) Showed Greater Reduction in Postprandial Glucose (PPG) vs. Humalog in Children, Adolescents, and Adult Patients with Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1018-P
- By:
- Publication type:
- Article
1112-P: Ultra Rapid Lispro (URLi) Lowers Postprandial Glucose (PPG) and More Closely Matches Normal Physiological Glucose Response Compared with Other Rapid Insulin Analogs.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1112-P
- By:
- Publication type:
- Article
1107-P: Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T1D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1107-P
- By:
- Publication type:
- Article
1100-P: Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T2D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1100-P
- By:
- Publication type:
- Article